Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEHAB II penile rehabilitation after nerve-sparing robot-assisted radical prostatectomy
2023-507466-40-00Phase 4Authorised
- Sponsor
- Netherlands Cancer Institute
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sildenafil in prostate cancer (PCa) (2 arms), sponsored by Netherlands Cancer Institute. Planned start Jan 2024; status: authorised.
02
Drugs
sildenafil
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2023-507466-40-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507466-40-00.